News Release

Zogenix to Participate in Cantor Fitzgerald Healthcare Conference


SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Cantor Fitzgerald Healthcare Conference in New York, NY, on July 8, 2015.

Cantor Fitzgerald Healthcare Conference

Date: Wednesday, July 8, 2015
Time: 1:00 pm Eastern Time / 10:00 am Pacific Time
Location: New York City

The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit

CONTACT: Investors: Andrew McDonald
         Founding Partner, LifeSci Advisors LLC
         646-597-6987 |

         Media: Catherine O'Connor
         Sr. Director, Corporate Communications, Zogenix
         858.436.3374 |
Zogenix, Inc.